Feasibility of recruitment to an oral dysplasia trial in the United Kingdom

BACKGROUND: Oral epithelial dysplasia (OED) has a malignant potential. Therapeutic options for OED remain both limited and without good evidence. Despite surgery being the most common method of treating OED, recurrence and potentially significant morbidity remain problematic. Consequently, there has...

Descripción completa

Detalles Bibliográficos
Autores principales: Nankivell, Paul, Dunn, Janet, Langman, Michael, Mehanna, Hisham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448506/
https://www.ncbi.nlm.nih.gov/pubmed/22731119
http://dx.doi.org/10.1186/1758-3284-4-40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448506/
https://www.ncbi.nlm.nih.gov/pubmed/22731119
http://dx.doi.org/10.1186/1758-3284-4-40

Ejemplares similares